Document:

Exhibit

EXECUTIVE SEVERANCE AND CHANGE IN CONTROL AGREEMENT 
This Executive Severance and Change in Control Agreement (the “Agreement”) is made this ____________ day of ____________, 2019, by and between Eventbrite, Inc., a Delaware corporation (the “Company”), and ____________ (the “Executive”).
WHEREAS, the Company and the Executive desire to enter into this Agreement, effective ____________ (the “Effective Date”), in order to, among other things, provide for certain severance benefits upon a termination of employment both in connection with a change of control of the company and in connection with certain events not involving a change in control of the Company.
NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements of the parties herein contained, the parties hereto agree as follows:
1.Purpose and Term.  
(a)    Purpose.  The Compensation Committee of the Board of Directors of the Company (the “Board”) has determined that appropriate steps should be taken to provide the Executive with competitive compensation and benefits arrangements in the event his or her employment is involuntarily terminated under certain circumstances.  Nothing in this Agreement shall be construed as creating an express or implied contract of employment; and, except as otherwise agreed in writing between the Executive and the Company, the Executive shall not have any right to be retained in the employ of the Company, any successor to the Company or any successor of any business of the Company.
(b)    Term. The terms of this Agreement shall commence on the Effective Date and shall continue until and including the third anniversary of the Effective Date unless earlier terminated as provided herein or extended as described in this paragraph (the “Initial Term”). The Initial Term shall be renewed automatically for periods of one year (each, an “Extended Term”) commencing at the third anniversary of the Effective Date and each subsequent anniversary thereof, unless written notice of non-renewal is given by the Company not less than 60 days prior to the end of the Initial Term or any Extended Term. As used herein, “Term” shall include the Initial Term and any Extended Term, but the Term shall end upon any termination of the Executive’s employment with the Company as provided herein. Notwithstanding the foregoing, in the event a Change in Control (as defined in Section 5(b)) occurs during the Initial Term or any Extended Term, the Term shall be extended until 12 months after the Change in Control.
2.Severance Benefits Not in Connection with a Change in Control.  If, during the Term, the Executive’s employment is terminated by the Company for any reason other than for Cause, Disability or death, subject to the Executive’s continued compliance with Section 6 hereof, the Executive signing a separation and release agreement containing, among other provisions, a general release of claims in favor of the Company and related persons and entities, confidentiality, return of property and non-disparagement, in a form and manner satisfactory to the Company (the “Separation Agreement and Release”), and the Separation Agreement and Release becoming irrevocable, all within 60 days after the earlier of (i) the Date of Termination or (ii) the date the Executive is provided with the Separation Agreement and Release (the “60-day Period”), the Executive shall be entitled to the following:  
(a)    The Company shall continue to pay to the Executive the Executive’s then current base salary for a period of six (6) months thereafter, in accordance with the Company’s regularly established payroll procedures.    
(b)    If the Executive was participating in the Company’s group health plan immediately prior to the Date of Termination and elects COBRA health continuation, then the Company shall pay to the Executive a monthly cash payment for 6 months or the Executive’s COBRA health continuation period, whichever ends earlier, in an amount equal to the monthly employer contribution that the Company would have made to provide health insurance to the Executive if the Executive had remained employed by the Company. 
(c)     The amounts payable under this Section 2 shall be paid or commence to be paid within 60 days after the Date of Termination; provided, however, that if the 60-day period begins in one calendar year and ends 

in a second calendar year, such payment shall be paid in the second calendar year by the last day of such 60-day period; provided, further, that the initial payment shall include a catch-up payment to cover amounts retroactive to the day immediately following the Date of Termination.  Each payment pursuant to this Section 2 is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2).
3.Change in Control Severance Benefits.  The provisions of this Section 3 are intended to assure and encourage in advance the Executive’s continued attention and dedication to his or her assigned duties and his or her objectivity during the pendency and after the occurrence of a Change in Control.  These provisions shall apply in lieu of, and expressly supersede, the provisions of Section 2 regarding severance pay and benefits upon a termination of employment, if such termination of employment occurs within 3 months before or 12 months after the occurrence of the first event constituting a Change in Control.  These provisions shall terminate and be of no further force or effect beginning 12 months after the occurrence of a Change in Control (provided that any obligation to satisfy payment obligations thereafter shall remain in effect until all such payments are made).
(a)    Change in Control Benefits.  If, during the Term, upon or within 3 months before or 12 months after a Change in Control, the Executive’s employment is terminated by the Company for any reason other than for Cause, Disability or death, or if the Executive terminates his or her employment for Good Reason (each a “Terminating Event”), then, subject to the Executive’s continued compliance with Section 6 hereof, the signing of the Separation Agreement and Release by the Executive, and the Separation Agreement and Release becoming irrevocable, all within 60 days after the Date of Termination: 
(i)    the Company shall continue to pay to the Executive the Executive’s base salary in effect on the date of the Terminating Event (or the Executive’s annual base salary in effect immediately prior to the Change in Control, if higher) for a period of twelve (12) months thereafter, in accordance with the Company’s regularly established payroll procedures;
(ii)    all equity awards held by the Executive shall immediately accelerate and become fully vested, exercisable (if applicable) and nonforfeitable; 
(iii)    if the Executive was participating in the Company’s group health plan immediately prior to the Date of Termination and elects COBRA health continuation, then the Company shall pay to the Executive a monthly cash payment for 12 months or the Executive’s COBRA health continuation period, whichever ends earlier, in an amount equal to the monthly employer contribution that the Company would have made to provide health insurance to the Executive if the Executive had remained employed by the Company; and
(iv)    the amounts payable under this Section 3(a) shall be paid or commence to be paid within 60 days after the Date of Termination; provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year, such payment shall be paid in the second calendar year by the last day of such 60-day period; provided, further, that the initial payment shall include a catch-up payment to cover amounts retroactive to the day immediately following the Date of Termination.  Each payment pursuant to this Section 3 is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2).
4.Additional Limitation under Section 280G.  
(a)    Anything in this Agreement to the contrary notwithstanding, in the event that the amount of any compensation, payment or distribution by the Company to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, calculated in a manner consistent with Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”), and the applicable regulations thereunder (the “Aggregate Payments”), would be subject to the excise tax imposed by Section 4999 of the Code, then the Aggregate Payments shall be reduced (but not below zero) so that the sum of all of the Aggregate Payments shall be $1.00 less than the amount at which the Executive becomes subject to the excise tax imposed by Section 4999 of the Code; provided that such reduction shall only occur if it would result in the Executive receiving a 

higher After Tax Amount (as defined below) than the Executive would receive if the Aggregate Payments were not subject to such reduction.  In such event, the Aggregate Payments shall be reduced in the following order, in each case, in reverse chronological order beginning with the Aggregate Payments that are to be paid the furthest in time from consummation of the transaction that is subject to Section 280G of the Code:  (1) cash payments not subject to Section 409A of the Code; (2) cash payments subject to Section 409A of the Code; (3) equity-based payments and acceleration; and (4) non-cash forms of benefits; provided that in the case of all the foregoing Aggregate Payments all amounts or payments that are not subject to calculation under Treas. Reg. §1.280G-1, Q&A-24(b) or (c) shall be reduced before any amounts that are subject to calculation under Treas. Reg. §1.280G-1, Q&A-24(b) or (c).
(b)    For purposes of this Section 4, the “After Tax Amount” means the amount of the Aggregate Payments less all federal, state, and local income, excise and employment taxes imposed on the Executive as a result of the Executive’s receipt of the Aggregate Payments.  For purposes of determining the After Tax Amount, the Executive shall be deemed to pay federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in which the determination is to be made, and state and local income taxes at the highest marginal rates of individual taxation in each applicable state and locality, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes. 
(c)    The determination as to whether a reduction in the Aggregate Payments shall be made pursuant to Section 4(a) shall be made by a nationally recognized accounting firm selected by the Company (the “Accounting Firm”) with the Executive’s consent, which will not be unreasonably withheld.  The Accounting Firm shall provide detailed supporting calculations both to the Company and the Executive within 15 business days of the Date of Termination, if applicable, or at such earlier time as is reasonably requested by the Company or the Executive.  Any determination by the Accounting Firm shall be binding upon the Company and the Executive.
5.Definitions.  For purposes hereof, the following terms shall have the meanings set forth below:
(a)    “Cause” shall mean:
(i)    the Executive’s material act of misconduct in connection with the performance of the Executive’s duties to the Company; or
(ii)    the Executive’s commission of any felony or a misdemeanor involving moral turpitude, deceit, dishonesty or fraud, or any conduct that would reasonably be expected to result in material injury or reputational harm to the Company or any of its subsidiaries or affiliates if the Executive were retained in the Executive’s position; or 
(iii)    the Executive’s continued non-performance of the Executive’s duties to the Company 30 days following written notice thereof from the Company; or
(iv)    the Executive’s breach of any material provisions of any written agreement between the Executive and the Company, including without limitation, the Proprietary Information and Invention Assignment Agreement; or
(v)    the Executive’s material violation of the Company’s written employment policies; or
(vi)    the Executive’s failure to cooperate with a bona fide internal investigation or an investigation by regulatory or law enforcement authorities, after being instructed by the Company to cooperate. 
(b)“Change in Control” shall mean a Sale Event (as defined in the Company’s 2018 Stock Option and Incentive Plan). 
Notwithstanding the foregoing, a “Change in Control” shall not be deemed to have occurred solely as the result of an acquisition of securities by the Company that, by reducing the number of shares of Voting Securities 

outstanding, increases the proportionate number of shares of Voting Securities beneficially owned by any person to 50 percent or more of the combined voting power of all then outstanding Voting Securities; provided, however, that if any person referred to in this sentence shall thereafter become the beneficial owner of any additional shares of Voting Securities (other than pursuant to a stock split, stock dividend, or similar transaction or as a result of an acquisition of securities directly from the Company) and immediately thereafter beneficially owns 50 percent or more of the combined voting power of all then outstanding Voting Securities, then a “Change in Control” shall be deemed to have occurred for purposes of this clause.  
(c)    “Date of Termination” shall mean: (i) if the Executive’s employment is terminated by the Company without Cause, the date set forth on the Notice of Termination; and (ii) if the Executive’s employment is terminated by the Executive with Good Reason, the date set forth on the Notice of Termination after the end of the Cure Period. Notwithstanding the foregoing, in the event that the Executive gives a Notice of Termination to the Company, the Company may unilaterally accelerate the Date of Termination and such acceleration shall not result in a separate termination by the Company for purposes of this Agreement.

(d)“Disability” shall mean that if, as a result of the Executive’s incapacity due to physical or mental illness, the Executive shall have been absent from his or her duties to the Company on a full-time basis for 180 calendar days in the aggregate in any 12 month period.
(e)“Good Reason” shall mean the Executive has complied with the “Good Reason Process” (hereinafter defined) following the occurrence of any of the following events without the Executive’s consent:
(i)    a material reduction in the Executive’s base salary except for across-the-board salary reductions based on the Company’s financial performance similarly affecting all or substantially all senior management employees of the Company; or
(ii)    a material diminution in the Executive’s authority, duties, or responsibilities; or 
(iii)    a material diminution in the authority, duties, or responsibilities of the supervisor to whom the Executive is required to report; or 
(iv)    a change of more than 50 miles in the geographic location in which the Executive must perform services for the Company.
(f)“Good Reason Process” shall mean that (1) the Executive reasonably determines in good faith that a “Good Reason” condition has occurred; (2) the Executive notifies the Company in writing of the first occurrence of the Good Reason condition within 45 days of the first occurrence of such condition; (3) the Executive cooperates in good faith with the Company’s efforts, for a period not less than 30 days following such notice (the “Cure Period”), to remedy the condition; (4) notwithstanding such efforts, the Good Reason condition continues to exist; and (5) the Executive terminates his or her employment within 60 days after the end of the Cure Period.  If the Company cures the Good Reason condition during the Cure Period, Good Reason shall be deemed not to have occurred.
(g)“Notice of Termination” shall mean a notice which shall indicate the specific termination provision in this Agreement relied upon.  Any termination of the Executive’s employment by the Company or any such termination by the Executive hereunder shall be communicated by written Notice of Termination to the other party hereto.  
6.Executive’s Covenant. The Executive has entered into a Proprietary Information and Invention Assignment Agreement with the Company dated on or before the Executive’s commencement of employment with the Company (the “Restrictive Covenant Agreement”), which is incorporated herein by reference and survives the termination or expiration of this Agreement.  In consideration of the benefits received under this Agreement, the Executive hereby reconfirms his or her obligations under the Restrictive Covenant Agreement in all respects, and understands that violation of the Executive’s obligations under the Restrictive Covenant Agreement will result in forfeiture of severance benefits under this Agreement.  The Executive understands that nothing contained in this 

Agreement or any other agreement limits the Executive’s ability to communicate with any federal, state or local governmental agency or commission, including to provide documents or other information to a governmental agency, without notice to the Company.  The Executive also understands that nothing in this Agreement or any other agreement limits the Executive’s ability to share compensation information concerning the Executive or others, except that this does not permit the Executive to disclose compensation information concerning others that the Executive obtains because the Executive’s job responsibilities require or allow access to such information. The Executive understands that pursuant to the federal Defend Trade Secrets Act of 2016, the Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
7.Termination. This Agreement shall terminate upon the earliest of (a) the termination by the Company of the employment of the Executive for Cause or the failure by the Executive to perform his or her full-time duties with the Company by reason of his or her death or Disability, (b) the resignation or termination of the Executive’s employment by the Executive without Good Reason, or (c) at the end of the then current Term following delivery of a notice of non-renewal under Section 1(b) herein (subject to the terms of such Section 1(b)).
8.Section 409A.
(a)Anything in this Agreement to the contrary notwithstanding, if at the time of the Executive’s separation from service within the meaning of Section 409A of the Code, the Company determines that the Executive is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that the Executive becomes entitled to under this Agreement on account of the Executive’s separation from service would be considered deferred compensation otherwise subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (A) six months and one day after the Executive’s separation from service, or (B) the Executive’s death.  If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a catch-up payment covering amounts that would otherwise have been paid during the six-month period but for the application of this provision, and the balance of the installments shall be payable in accordance with their original schedule.
(b)All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company or incurred by the Executive during the time periods set forth in this Agreement.  All reimbursements shall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred.  The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year shall not affect the in-kind benefits to be provided or the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses).  Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.
(c)To the extent that any payment or benefit described in this Agreement constitutes “non-qualified deferred compensation” under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the Executive’s termination of employment, then such payments or benefits shall be payable only upon the Executive’s “separation from service.”  The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation Section 1.409A-1(h). 
(d)The parties intend that this Agreement will be administered in accordance with Section 409A of the Code.  To the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in such a manner so that all payments hereunder comply with Section 409A of the Code.  Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2).  The parties agree that this Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with Section 409A of the Code and all related rules 

and regulations in order to preserve the payments and benefits provided hereunder without additional cost to either party. 
(e)The Company makes no representation or warranty and shall have no liability to the Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an exemption from, or the conditions of, such Section.
9.Litigation and Regulatory Cooperation.  During and after the Executive’s employment, the Executive shall cooperate fully with the Company in the defense or prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company which relate to events or occurrences that transpired while the Executive was employed by the Company.  The Executive’s full cooperation in connection with such claims or actions shall include, but not be limited to, being available to meet with counsel to prepare for discovery or trial and to act as a witness on behalf of the Company at mutually convenient times. During and after the Executive’s employment, the Executive also shall cooperate fully with the Company in connection with any investigation or review of any federal, state or local regulatory authority as any such investigation or review relates to events or occurrences that transpired while the Executive was employed by the Company.  Any cooperation pursuant to this Section 9 is subject to the Company’s obligation to reimburse the Executive for any reasonable expenses incurred during activities performed at the Company’s request pursuant to this Section 9, subject to the same standards and procedures as apply to business expense reimbursements pursuant to the Company’s Travel and Expense reimbursement policy. 
10.Arbitration of Disputes. Any controversy or claim arising out of or relating to this Agreement or the breach thereof or otherwise arising out of the Executive’s employment or the termination of that employment (including, without limitation, any claims of unlawful employment discrimination whether based on age or otherwise and any other claims based on any statute) shall, to the fullest extent permitted by law, be settled by arbitration in any forum and form agreed upon by the parties or, in the absence of such an agreement, under the auspices of the American Arbitration Association (“AAA”) in San Francisco, California in accordance with the Employment Arbitration Rules of the AAA, including, but not limited to, the rules and procedures applicable to the selection of arbitrators.  In the event that any person or entity other than the Executive or the Company may be a party with regard to any such controversy or claim, such controversy or claim shall be submitted to arbitration subject to such other person or entity’s agreement. Judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof.  This Section 10 shall be specifically enforceable. Notwithstanding the foregoing, this Section 10 shall not preclude either party from pursuing a court action for the sole purpose of obtaining a temporary restraining order or a preliminary injunction in circumstances in which such relief is appropriate; provided that any other relief shall be pursued through an arbitration proceeding pursuant to this Section 10. 
11.Consent to Jurisdiction. To the extent that any court action is permitted consistent with or to enforce Section 10 of this Agreement, the parties hereby consent to the jurisdiction of the Superior Court of the State of California and the United States District Court for the Northern District of California. Accordingly, with respect to any such court action, the Executive (a) submits to the personal jurisdiction of such courts; (b) consents to service of process; and (c) waives any other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction or service of process.  
12.Integration.  This Agreement, together with the additional agreements referred to herein, constitute the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements between the parties concerning such subject matter, including, without limitation, the provisions of the Employment Offer Letter, dated as of July 17, 2017, by and between the Executive and the Company, regarding the acceleration of the Executive’s option award.
13.Effect on Other Plans.  An election by the Executive to resign for Good Reason under the provisions of this Agreement shall not be deemed a voluntary termination of employment by the Executive for the purpose of interpreting the provisions of any of the Company’s benefit plans, programs or policies.  Nothing in this Agreement shall be construed to limit the rights of the Executive under the Company’s benefit plans, programs or policies except that the Executive shall have no rights to any severance benefits under any Company severance pay plan.

14.Withholding.  All payments made by the Company to the Executive under this Agreement shall be net of any tax or other amounts required to be withheld by the Company under applicable law.
15.Successor to the Executive.  This Agreement shall inure to the benefit of and be enforceable by the Executive’s personal representatives, executors, administrators, heirs, distributees, devisees and legatees.  
16.Enforceability.  If any portion or provision of this Agreement (including, without limitation, any portion or provision of any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.
17.Survival.  The provisions of this Agreement shall survive the termination of this Agreement and/or the termination of the Executive’s employment to the extent necessary to effectuate the terms contained herein.
18.Waiver.  No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party.  The failure of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.
19.Notices.  Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return receipt requested, to the Executive at the last address the Executive has filed in writing with the Company or, in the case of the Company, at its main offices, attention of the Chief Executive Officer.
20.Amendment.  This Agreement may be amended or modified only by a written instrument signed by the Executive and by a duly authorized representative of the Company.
21.Governing Law.  This is a California contract and shall be construed under and be governed in all respects by the laws of the State of California, without giving effect to the conflict of laws principles of such State.    
22.Counterparts.  This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be taken to be an original; but such counterparts shall together constitute one and the same document.
23.Successor to Company.  The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company expressly to assume and agree to perform this Agreement to the same extent that the Company would be required to perform it if no succession had taken place.  Failure of the Company to obtain an assumption of this Agreement at or prior to the effectiveness of any succession shall be a material breach of this Agreement.
24.Gender Neutral.  Wherever used herein, a pronoun in the masculine gender shall be considered as including the feminine gender unless the context clearly indicates otherwise.

IN WITNESS WHEREOF, this Agreement has been executed as a sealed instrument by the Company by its duly authorized officer, and by the Executive, as of the date first above written.
            
EVENTBRITE, INC.

                                                                                                            ___________________________
By: Julia Hartz, CEO

        ___________________________
Executive:Exhibit 10.1

 

SECURITIES
PURCHASE AGREEMENT

 

This
SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of April 25, 2019 by and among China Green Agriculture,
Inc., a Nevada corporation, (the “Company”), and individuals listed in Exhibit B hereto and each affixes
its signature on the signature page of this Agreement (each, a “Purchaser”; collectively, the “Purchasers”).

 

RECITALS

 

WHEREAS,
the Company and the Purchasers are executing and delivering this Agreement in accordance with and in reliance upon the exemption
from securities registration afforded by Section 4(2) of the Securities Act of 1933 (the “Securities Act”) and/or
Regulation S (“Regulation S”) as promulgated under the Securities Act;

 

WHEREAS,
the Company is offering certain shares of its common stock, par value $0.001 per share, (the “Common Stock”) at price
of $1.00 per share to the Purchasers;

 

WHEREAS,
the Company is offering up to 6,000,000 shares of Common Stock to the Purchasers listed in Exhibit A, who severally but not jointly
enters into this Agreement and makes representations and warranties hereunder;

 

WHEREAS,
the Purchaser is a “non-US person” as defined in Regulation S, acquiring the Shares solely for its own account for
the purpose of investment;

 

NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration,
the receipt and adequacy of which are hereby acknowledged, the Company and the Purchaser hereby agree as follows:

 

     

     

    

 

ARTICLE
I

 

Purchase
and Sale of the Shares

 

Section
1.1 Purchase Price and Closing.

 

(a) Subject
to the terms and conditions hereof, the Company agrees to issue and sell to the Purchaser and, in consideration of and in express
reliance upon the representations, warranties, covenants, terms and conditions of this Agreement, the Purchaser agrees to purchase
for $1.00 per Share, such number of shares of Common Stock (each a “Share” and collectively the “Shares")
for an aggregate price of listed on the signature page hereto (the “Purchase Price").

 

(b) Subject
to all conditions to closing being satisfied or waived, the closing of the purchase and sale of the Shares (the “Closing”)
shall take place at the offices of the Company’s headquater in Xi’an, on the date of the occurrence of completion
of and receipt by the Company of the Purchase Price (the “Closing Date”).

 

(c) Subject
to the terms and conditions of this Agreement, at the Closing the Company shall deliver or cause to be delivered to the Purchaser
(i) a certificate for such number of Shares, and (ii) any other documents required to be delivered pursuant to this Agreement.
At the time of the Closing, the Purchaser shall have delivered its Purchase Price by wire transfer pursuant to the wire information
contained in this Agreement or by check.

 

ARTICLE
II

 

Representations
and Warranties

 

Section
2.1 Representations and Warranties of the Company and its Subsidiaries. The Company hereby represents and warrants to
the Purchaser on behalf of itself, its Subsidiaries (as hereinafter defined), as of the date hereof (except as set forth on the
Schedule of Exceptions attached hereto with each numbered Schedule corresponding to the section number herein), as follows:

 

(a) Organization,
Good Standing and Power. The Company is a corporation or other entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of its jurisdiction of incorporation or organization (as applicable) and respectively, has
the requisite corporate power to own, lease and operate its properties and assets and to conduct its business as it is now being
conducted. Except as set forth on Schedule 2.1(a), the Company and each of its Subsidiaries is duly qualified to do business
and is in good standing in every jurisdiction in which the nature of the business conducted or property owned by it makes such
qualification necessary except for any jurisdiction(s) (alone or in the aggregate) in which the failure to be so qualified will
not have a Material Adverse Effect (as defined in Section 2.1(g) hereof).

 

(b) Corporate
Power; Authority and Enforcement. The Company has the requisite corporate power and authority to enter into and perform its
obligations under this Agreement, and to issue and sell the Shares in accordance with the terms hereof. The execution, delivery
and performance of this Agreement by the Company and the consummation by it of the transactions contemplated hereby and thereby
have been duly and validly authorized by all necessary corporate action, and no further consent or authorization of the Company
or its Board of Directors or stockholders is required. This Agreement constitutes, or shall constitute when executed and delivered,
a valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservator ship, receiver ship
or similar laws relating to, or affecting generally the enforcement of, creditor’s rights and remedies or by other equitable
principles of general application.

 

    2

     

    

 

(c) Capitalization.
The authorized capital stock of the Company and the shares thereof currently issued and outstanding as of April 22, 2019 are set
forth in the Company’s Form 10-Q Quarterly Report for the period ended Decemeber 31, 2018 (the “Form 10-Q”)
and, are the authorized and issued and outstanding capital stock of the Company as at the date hereof. Except as set forth in
the on Schedule 2.1(c) hereto,

 

 (i)
there are no material contracts, commitments, understandings, or arrangements by which the Company is or may become bound to issue
additional shares of capital stock of the Company or options, securities or rights convertible into shares of capital stock of
the Company;

 

 (ii)
the Company is not a party to any agreement granting registration or anti-dilution rights to any person with respect to any of
its equity or debt securities;

 

 (iii)
the Company is not a party to, and it has no knowledge of, any agreement restricting the voting or transfer of any shares of the
capital stock of the Company.

 

(iv)
The offer and sale of all capital stock, convertible securities, rights, warrants, or options of the Company issued prior to
the Closing complied with all applicable Federal and state securities laws, except where non-compliance would not have a
Material Adverse Effect. The Company has furnished or made available to the Purchaser true and correct copies of the
Company’s Articles of Incorporation, as amended and in effect on the date hereof (the “Articles”),
and the Company’s Bylaws, as amended and in effect on the date hereof (the “Bylaws”). Except as
restricted under applicable federal, state, local or foreign laws and regulations, the Articles, this Agreement, or as set
forth on Schedule 2.1 (c), no written or oral contract, instrument, agreement, commitment, obligation, plan or
arrangement of the Company shall limit the payment of dividends on the Company’s Preferred Shares, or its Common
Stock.

 

(d) Issuance
of Shares. The Shares to be issued at the Closing have been duly authorized by all necessary corporate action and the Preferred
Shares, when paid for or issued in accordance with the terms hereof, shall be validly issued and outstanding, fully paid and non-assessable.

 

(e) Subsidiaries.
As of the date of this Agreement, other than as disclosed in the Company’s Commission Documents, the Company does not have
any other subsidiary.

 

    3

     

    

 

(f)
 Commission Documents, Financial Statements. Except as set forth in Schedule 2.1
(f), the Company has filed all reports, schedules, forms, statements and other documents required to be filed by it with the U.S.
Securities and Exchange Commission (the “Commission” or “SEC”) pursuant to the reporting requirements
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including the Form 10-Q and other
material filed pursuant to Section 13(a) or 15(d) of the Exchange Act (all of the foregoing including filings incorporated by
reference therein being referred to herein as the “Commission Documents”). The Company has not provided to
the Purchaser any material non-public information or other information which, according to applicable law, rule or regulation,
was required to have been disclosed publicly by the Company but which has not been so disclosed, other than (i) with respect to
the transactions contemplated by this Agreement, or (ii) pursuant to a non-disclosure or confidentiality agreement signed by the
Purchaser. At the time of the respective filings, the Form 10-K’s and the Form 10-Q’s complied in all material respects
with the requirements of the Exchange Act and the rules and regulations of the Commission promulgated thereunder and other federal,
state and local laws, rules and regulations applicable to such documents. As of their respective filing dates, none of the Form
10-K’s or Form 10-Q’s contained any untrue statement of a material fact; and none omitted to state a material fact
required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which
they were made, not misleading. The financial statements of the Company included in the Commission Documents comply as to form
in all material respects with applicable accounting requirements and the published rules and regulations of the Commission or
other applicable rules and regulations with respect thereto. Such financial statements have been prepared in accordance with United
States generally accepted accounting principles (“GAAP”) applied on a consistent basis during the periods involved
(except (i) as may be otherwise indicated in such financial statements or the notes thereto or (ii) in the case of unaudited interim
statements, to the extent they may not include footnotes or may be condensed or summary statements), and fairly present in all
material respects the consolidated financial position of the Company as of the dates thereof and the results of operations and
cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).

 

(g) No
Material Adverse Effect. As of December 31, 2018 till the date of this Agreement, the Company have not experienced or suffered
any Material Adverse Effect. For the purposes of this Agreement, “Material Adverse Effect” shall mean (i) any material
adverse effect upon the assets, properties, financial condition, business or prospects of the Company, and its Subsidiaries, when
taken as a consolidated whole, and/or (ii) any condition, circumstance, or situation that would prohibit or otherwise materially
interfere with the ability of the Company to perform any of its material covenants, agreements and obligations under this Agreement.

 

(h) No
Undisclosed Liabilities. Other than as disclosed in the Company’s Commission Documents or on Schedule 2.1(h)
to the knowledge of the Company, neither the Company, nor the Subsidiaries has any liabilities, obligations, claims or losses
(whether liquidated or unliquidated, secured or unsecured, absolute, accrued, contingent or otherwise) other than those incurred
in the ordinary course of the Company’s and the Subsidiaries’ respective businesses and which, individually or in
the aggregate, do not or would not have a Material Adverse Effect.

 

(i) No
Undisclosed Events or Circumstances. To the Company’s knowledge, no event or circumstance has occurred or exists with
respect to the Company, the Subsidiaries or their respective businesses, properties, operations or financial condition, which,
under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so
publicly announced or disclosed.

 

    4

     

    

 

(j) Title
to Assets. Except where non-compliance would not have a Material Adverse Effect, each of the Company and the Subsidiaries
has good and marketable title to (i) all properties and assets purportedly owned or used by them as reflected in the Financial
Statements, (ii) all properties and assets necessary for the conduct of their business as currently conducted, and (iii) all of
the real and personal property reflected in the Financial Statements free and clear of any Lien. All leases are valid and subsisting
and in full force and effect.

 

(k) Actions
Pending. There is no action, suit, claim, investigation, arbitration, alternate dispute resolution proceeding or any other
proceeding pending or, to the knowledge of the Company, threatened against or involving the Company which questions the validity
of this Agreement or the transactions contemplated hereby or thereby or any action taken or to be taken pursuant hereto or thereto.
Except where the same would not have a Material Adverse Effect, there is no action, suit, claim, investigation, arbitration, alternate
dispute resolution proceeding or any other proceeding pending or, to the knowledge of the Company, threatened against or involving
the Company involving any of their respective properties or assets. To the knowledge of the Company, there are no outstanding
orders, judgments, injunctions, awards or decrees of any court, arbitrator or governmental or regulatory body against the Company,
the Subsidiaries or any of their respective executive officers or directors in their capacities as such.

 

(l) Compliance
with Law. The Company and the Subsidiaries have all material franchises, permits, licenses, consents and other governmental
or regulatory authorizations and approvals necessary for the conduct of their respective business as now being conducted by it
unless the failure to possess such franchises, permits, licenses, consents and other governmental or regulatory authorizations
and approvals, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect.

 

(m) No
Violation. The business of the Company and the Subsidiaries is not being conducted in violation of any Federal, state, local
or foreign governmental laws, or rules, regulations and ordinances of any of any governmental entity, except for possible violations
which singularly or in the aggregate could not reasonably be expected to have a Material Adverse Effect. The Company is not required
under Federal, state, local or foreign law, rule or regulation to obtain any consent, authorization or order of, or make any filing
or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under
this Agreement, or issue and sell the Shares in accordance with the terms hereof or thereof (other than (x) any consent, authorization
or order that has been obtained as of the date hereof, (y) any filing or registration that has been made as of the date hereof
or (z) any filings which may be required to be made by the Company with the Commission or state securities administrators subsequent
to the Closing.)

 

(n) No
Conflicts. The execution, delivery and performance of this Agreement by the Company and the consummation by the Company of
the transactions contemplated herein and therein do not and will not (i) violate any provision of the Company’s Certificate
or Bylaws, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, mortgage,
deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Company is a party or by
which it or its properties or assets are bound, (iii) create or impose a lien, mortgage, security interest, pledge, charge or
encumbrance (collectively, “Lien”) of any nature on any property of the Company under any agreement or any
commitment to which the Company is a party or by which the Company is bound or by which any of its respective properties or assets
are bound, or (iv) result in a violation of any federal, state, local or foreign statute, rule, regulation, order, judgment or
decree (including Federal and state securities laws and regulations) applicable to the Company or any of its subsidiaries or by
which any property or asset of the Company or any of its subsidiaries are bound or affected, provided, however,
that, excluded from the foregoing in all cases are such conflicts, defaults, terminations, amendments, accelerations, cancellations
and violations as would not, individually or in the aggregate, have a Material Adverse Effect.

 

    5

     

    

 

(o) Certain
Fees. Except as set forth on Schedule 2.1(o) hereto, no brokers fees, finders fees or financial advisory fees or commissions
will be payable by the Company with respect to the transactions contemplated by this Agreement.

 

(p) Disclosure.
Except as set forth in Schedule 2.1(p), neither this Agreement nor the Schedules hereto nor any other documents, certificates
or instruments furnished to the Purchaser by or on behalf of the Company or the Subsidiaries in connection with the transactions
contemplated by this Agreement contain any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements made herein or therein, taken as a whole and in the light of the circumstances under which they were made
herein or therein, not false or misleading.

 

(q) Intellectual
Property. Each of the Company and the Subsidiaries owns or has the lawful right to use all patents, trademarks, domain names
(whether or not registered) and any patentable improvements or copyrightable derivative works thereof, websites and intellectual
property rights relating thereto, service marks, trade names, copyrights, licenses and authorizations, and all rights with respect
to the foregoing, which are necessary for the conduct of their respective business as now conducted without any conflict with
the rights of others, except where the failure to so own or possess would not have a Material Adverse Effect.

 

(r) Books
and Record Internal Accounting Controls. Except as may have otherwise been disclosed in the Form 10-Ks or the Form 10-Qs,
the books and records of the Company and the Subsidiaries accurately reflect in all material respects the information relating
to the business of the Company and the Subsidiaries, the location and collection of their assets, and the nature of all transactions
giving rise to the obligations or accounts receivable of the Company, or the Subsidiaries. Except as disclosed in the Company’s
Commission Documents or on Schedule 2.1(r), the Company and the Subsidiaries maintain a system of internal accounting controls
sufficient, in the judgment of the Company, to provide reasonable assurance that (i) transactions are executed in accordance with
management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance
with management’s general or specific authorization and (iv) the recorded accountability for assets is compared with the
existing assets at reasonable intervals and appropriate actions are taken with respect to any differences.

 

(s) Material
Agreements. Any and all written or oral contracts, instruments, agreements, commitments, obligations, plans or arrangements,
the Company and the Subsidiaries is a party to, that a copy of which would be required to be filed with the Commission as an exhibit
to a registration statement on Form S-1 (collectively, the “Material Agreements”) if the Company were registering
securities under the Securities Act has previously been publicly filed with the Commission in the Commission Documents. Each of
the Company and the Subsidiaries has in all material respects performed all the obligations required to be performed by them to
date under the foregoing agreements, have received no notice of default and are not in default under any Material Agreement now
in effect the result of which would cause a Material Adverse Effect.

 

    6

     

    

 

(t) Transactions
with Affiliates. Except as set forth in the Financial Statements or in the Commission Documents, there are no loans, leases,
agreements, contracts, royalty agreements, management contracts or arrangements or other continuing transactions between (a) the
Company on the one hand, and (b) on the other hand, any officer, employee, consultant or director of the Company or any person
owning any capital stock of the Company or any member of the immediate family of such officer, employee, consultant, director
or stockholder or any corporation or other entity controlled by such officer, employee, consultant, director or stockholder, or
a member of the immediate family of such officer, employee, consultant, director or stockholder.

 

Section
2.2 Representations and Warranties of the Purchaser. Each Purchaser, severally but not jointly, hereby makes the following
representations and warranties to the Company as of the date hereof:

 

(a) No
Conflicts. The execution, delivery and performance of this Agreement and the consummation by such Purchaser of the transactions
contemplated hereby and thereby or relating hereto do not and will not conflict with, or constitute a default (or an event which
with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of any agreement, indenture or instrument or obligation to which such Purchaser is a party or by which its properties
or assets are bound, or result in a violation of any law, rule, or regulation, or any order, judgment or decree of any court or
governmental agency applicable to such Purchaser or its properties (except for such conflicts, defaults and violations as would
not, individually or in the aggregate, have a material adverse effect on such Purchaser). Such Purchaser is not required to obtain
any consent, authorization or order of, or make any filing or registration with, any court or governmental agency in order for
it to execute, deliver or perform any of its obligations under this Agreement, provided, that for purposes of the representation
made in this sentence, such Purchaser is assuming and relying upon the accuracy of the relevant representations and agreements
of the Company herein.

 

(b) Status
of Purchaser. The Purchaser is a “non-US person” as defined in Regulation S. The Purchaser further makes the representations
and warranties to the Company set forth on Exhibit A. Such Purchaser is not required to be registered as a broker-dealer
under Section 15 of the Exchange Act and such Purchaser is not a broker-dealer, nor an affiliate of a broker-dealer.

 

(c) Reliance
on Exemptions. The Purchaser understands that the Shares are being offered and sold to it in reliance upon specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying upon the
truth and accuracy of, and the Purchaser’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility
of the Purchaser to acquire the Shares.

 

    7

     

    

 

(d) Information.
The Purchaser and its advisors, if any, have had the opportunity to ask questions of management of the Company and its Subsidiaries
and have been furnished with all information relating to the business, finances and operations of the Company and information
relating to the offer and sale of the Shares which have been requested by the Purchaser or its advisors. Neither such inquiries
nor any other due diligence investigation conducted by the Purchaser or any of its advisors or representatives shall modify, amend
or affect the Purchaser’s right to rely on the representations and warranties of the Company contained herein. The Purchaser
understands that its investment in the Shares involves a significant degree of risk. The Purchaser further represents to the Company
that the Purchaser’s decision to enter into this Agreement has been based solely on the independent evaluation of the Purchaser
and its representatives.

 

(e) Governmental
Review. The Purchaser understands that no United States federal or state agency or any other government or governmental agency
has passed upon or made any recommendation or endorsement of the Shares.

 

 (f) Transfer
or Re-sale. The Purchaser understands that the sale or re-sale of the Shares has not been and is not being registered under
the Securities Act or any applicable state securities laws, and the Shares may not be transferred unless (i) the Shares are sold
pursuant to an effective registration statement under the Securities Act, (ii) the Purchaser shall have delivered to the Company
an opinion of counsel that shall be in form, substance and scope customary for opinions of counsel in comparable transactions
to the effect that the Shares to be sold or transferred may be sold or transferred pursuant to an exemption from such registration,
which opinion shall be reasonably acceptable to the Company, (iii) the Shares are sold or transferred to an “affiliate”
(as defined in Rule 144 promulgated under the Securities Act (or a successor rule) (“Rule 144”)) of the Purchaser
who agrees to sell or otherwise transfer the Shares only in accordance with this Section 2.2(f) and who is a non-US person, (iv)
the Shares are sold pursuant to Rule 144, or (v) the Shares are sold pursuant to Regulation S under the Securities Act (or a successor
rule) (“Regulation S”). Notwithstanding the foregoing or anything else contained herein to the contrary, the
Shares may be pledged as collateral in connection with a bona fide margin account or other lending arrangement.

 

(g) Legends.
The Purchaser understands that the Shares shall bear a restrictive legend in the form as set forth under Section 5.1 of this Agreement.
The Purchaser understands that, until such time the Shares may be sold pursuant to Rule 144 or Regulation S without any restriction
as to the number of securities as of a particular date that can then be immediately sold, the Shares may bear a restrictive legend
in substantially the form set forth under Section 5.1 (and a stop-transfer order may be placed against transfer of the certificates
evidencing such Securities).

 

(h) Residency.
The Purchaser is a resident of the jurisdiction set forth immediately below such Purchaser’s name on the signature pages
hereto.

 

(i) No
General Solicitation. The Purchaser acknowledges that the Shares were not offered to such Purchaser by means of any form of
general or public solicitation or general advertising, or publicly disseminated advertisements or sales literature, including
(i) any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media, or broadcast
over television or radio, or (ii) any seminar or meeting to which such Purchaser was invited by any of the foregoing means of
communications.

 

    8

     

    

 

(j) Rule
144. Such Purchaser understands that the Shares must be held indefinitely unless such Shares are registered under the Securities
Act or an exemption from registration is available. Such Purchaser acknowledges that such Purchaser is familiar with Rule 144
and Rule 144A, of the rules and regulations of the Commission, as amended, promulgated pursuant to the Securities Act (“Rule
144”), and that such person has been advised that Rule 144 and Rule 144A, as applicable, permits resales only under
certain circumstances. Such Purchaser understands that to the extent that Rule 144 or Rule 144A is not available, such Purchaser
will be unable to sell any Shares without either registration under the Securities Act or the existence of another exemption from
such registration requirement.

 

(j) Brokers.
Purchaser does not have any knowledge of any brokerage or finder’s fees or commissions that are or will be payable by the
Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other person or entity
with respect to the transactions contemplated by this Agreement.

 

(k) Acquisition
for Investment. The Purchaser is a “non-US person” as defined in Regulation S, acquiring the Shares solely for
the its own account for the purpose of investment and not with a view to or for sale in connection with a distribution to anyone.

 

ARTICLE
III

 

Covenants

 

The
Company covenants with the Purchaser as follows, which covenants are for the benefit of the Purchaser and its permitted assignees
(as defined herein).

 

Section
3.1 Securities Compliance. The Company shall notify the Commission in accordance with its rules and regulations, of
the transactions contemplated by any of this Agreement, and shall take all other necessary action and proceedings as may be required
and permitted by applicable law, rule and regulation, for the legal and valid issuance of the Shares to the Purchaser or subsequent
holders.

 

Section
3.2 Confidential Information. The Purchaser agrees that such Purchaser and its employees, agents and representatives
will keep confidential and will not disclose, divulge or use (other than for purposes of monitoring its investment in the Company)
any confidential information which such Purchaser may obtain from the Company pursuant to financial statements, reports and other
materials submitted by the Company to such Purchaser pursuant to this Agreement, unless such information is known to the public
through no fault of such Purchaser or his or its employees or representatives; provided, however, that a Purchaser may disclose
such information (i) to its attorneys, accountants and other professionals in connection with their representation of such Purchaser
in connection with such Purchaser’s investment in the Company, (ii) to any prospective permitted transferee of the Shares,
so long as the prospective transferee agrees to be bound by the provisions of this Section 3.3, or (iii) to any general partner
or affiliate of such Purchaser.

 

Section
3.3 Compliance with Laws. The Company shall comply to comply in all material respects, with all applicable laws,
rules, regulations and orders, except where non-compliance could not reasonably be expected to have a Material Adverse
Effect.

 

    9

     

    

 

Section
3.4 Keeping of Records and Books of Account. The Company shall keep adequate records and books of account, in which
complete entries will be made in accordance with GAAP consistently applied, reflecting all financial transactions of the Company,
and in which, for each fiscal year, all proper reserves for depreciation, depletion, obsolescence, amortization, taxes, bad debts
and other purposes in connection with its business shall be made.

 

Section
3.5 Disclosure of Material Information. The Company covenants and agrees that neither it nor any other person acting
on its or their behalf has provided or, from and after the filing of the Press Release, will provide any Purchaser or its agents
or counsel with any information that the Company believes constitutes material non-public information (other than with respect
to the transactions contemplated by this Agreement), unless prior thereto such Purchaser shall have executed a specific written
agreement regarding the confidentiality and use of such information. The Company understands and confirms that the Purchaser shall
be relying on the foregoing covenants in effecting transactions in securities of the Company. At the time of the filing of the
Press Release, no Purchaser shall be in possession of any material, nonpublic information received from the Company, any of its
subsidiaries or any of its respective officers, directors, employees or agents, that is not disclosed in the Press Release. The
Company shall not disclose the identity of any Purchaser in any filing with the SEC except as required by the rules and regulations
of the SEC thereunder. In the event of a breach of the foregoing covenant by the Company, , or any of its or their respective
officers, directors, employees and agents, in addition to any other remedy provided herein, a Purchaser may notify the Company,
and the Company shall make public disclosure of such material nonpublic information within two (2) trading days of such notification.

 

Section
3.6 No Manipulation of Price. The Company will not take, directly or indirectly, any action designed to cause or result
in, or that has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any
securities of the Company.

 

ARTICLE
IV

 

CONDITIONS

 

Section
4.1 Conditions Precedent to the Obligation of the Company to Sell the Shares. The obligation hereunder of the Company
to issue and sell the Shares is subject to the satisfaction or waiver, at or before the Closing, of each of the conditions set
forth below. These conditions are for the Company’s sole benefit and may be waived by the Company at any time in its sole
discretion.

 

(a) Accuracy
of the Purchaser’s Representations and Warranties. The representations and warranties of the Purchaser in this Agreement
shall be true and correct in all material respects as of the date when made and as of the Closing Date as though made at that
time, except for representations and warranties that are expressly made as of a particular date, which shall be true and correct
in all material respects as of such date.

 

(b) Performance
by the Purchaser. The Purchaser shall have performed, satisfied and complied in all respects with all covenants, agreements
and conditions required by this Agreement to be performed, satisfied or complied with by such Purchaser at or prior to the Closing.

 

    10

     

    

 

(c) No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of any
of the transactions contemplated by this Agreement.

 

(d) Delivery
of Purchase Price. The Purchase Price for the Shares shall have been delivered to the Company.

 

(e) Delivery
of this Agreement. This Agreement shall have been duly executed and delivered by the Purchaser to the Company.

 

(f) Receipt
of NYSE’s Approval. The Company shall receive from NYSE the approval of the application for the listing of the
Shares, if required.

 

Section
4.2 Conditions Precedent to the Obligation of the Purchaser to Purchase the Shares. The obligation hereunder of the
Purchaser to acquire and pay for the Shares offered in Offering is subject to the satisfaction or waiver, at or before the Closing,
of each of the conditions set forth below. These conditions are for the Purchaser’s sole benefit and may be waived by such
Purchaser at any time in its sole discretion.

 

(a) Accuracy
of the Company’s Representations and Warranties. Each of the representations and warranties of the Company in this Agreement
shall be true and correct in all respects as of the date when made and as of the Closing Date as though made at that time, except
for representations and warranties that are expressly made as of a particular date, which shall be true and correct in all respects
as of such date.

 

(b) Performance
by the Company. The Company shall have performed, satisfied and complied in all respects with all covenants, agreements and
conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing.

 

(c) No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of any
of the transactions contemplated by this Agreement.

 

(d) No
Proceedings or Litigation. No action, suit or proceeding before any arbitrator or any governmental authority shall have been
commenced, and no investigation by any governmental authority shall have been threatened, against the Company, or any of the officers,
directors or affiliates of the Company seeking to restrain, prevent or change the transactions contemplated by this Agreement,
or seeking damages in connection with such transactions.

 

(e)
Certificates. The Company shall have executed and delivered to the Purchaser the certificates (in such denominations as
such Purchaser shall request) for the Shares being acquired by such Purchaser immediately after the Closing (in such denominations
as such Purchaser shall request) to such address set forth next to the Purchaser with respect to the Closing.

 

    11

     

    

 

(f) Resolutions.
The Board of Directors of the Company shall have adopted resolution consistent with Section 2.1(b) hereof in a form reasonably
acceptable to such Purchaser (the “Resolution”).

 

(g) Material
Adverse Effect. No Material Adverse Effect shall have occurred at or before the Closing Date.

 

ARTICLE
V

 

Stock
Certificate Legend

 

Section
5.1 Legend. Each certificate representing the Shares shall be stamped or otherwise imprinted with a legend substantially
in the following form (in addition to any legend required by applicable state securities or “blue sky” laws):

 

THESE
SECURITIES REPRESENTED BY THIS CERTIFICATE (THE “SECURITIES”) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”). THE SECURITIES WERE ISSUED IN A TRANSACTION EXEMPT FROM THE REGISTRATION
REDISTRICTIREMENTS OF THE SECURITIES ACT PURSUANT TO REGULATION S PROMULGATED UNDER IT. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED
OR OTHERWISE DISPOSED OF IN THE UNITED STATES UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES
LAWS OR THE COMPANY SHALL HAVE RECEIVED AN OPINION OF COUNSEL THAT REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT IS
NOT REDISTRICTIRED. FURTHER, HEDGING TRANSACTIONS WITH REGARD TO THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH
THE SECURITIES ACT.

 

ARTICLE
VI

 

Indemnification

 

Section
6.1 General Indemnity. The Company agrees to indemnify and hold harmless the Purchaser (and their respective directors,
officers, managers, partners, members, shareholders, affiliates, agents, successors and assigns) from and against any and all
losses, liabilities, deficiencies, costs, damages and expenses (including, without limitation, reasonable attorneys’ fees,
charges and disbursements) incurred by the Purchaser as a result of any inaccuracy in or breach of the representations, warranties
or covenants made by the Company herein. The Purchaser, severally but not jointly, agrees to indemnify and hold harmless the Company
and its directors, officers, affiliates, agents, successors and assigns from and against any and all losses, liabilities, deficiencies,
costs, damages and expenses (including, without limitation, reasonable attorneys’ fees, charges and disbursements) incurred
by the Company as a result of any inaccuracy in or breach of the representations, warranties or covenants made by such Purchaser
herein. The maximum aggregate liability of the Purchaser pursuant to its indemnification obligations under this Article VI shall
not exceed the portion of the Purchase Price paid by the Purchaser hereunder. In no event shall any “Indemnified Party”
(as defined below) be entitled to recover consequential or punitive damages resulting from a breach or violation of this Agreement.

 

    12

     

    

 

Section
6.2 Indemnification Procedure. Any party entitled to indemnification under this Article VI (an “Indemnified
Party”) will give written notice to the indemnifying party of any matters giving rise to a claim for indemnification;
provided, that the failure of any party entitled to indemnification hereunder to give notice as provided herein shall not
relieve the indemnifying party of its obligations under this Article VI except to the extent that the indemnifying party is actually
prejudiced by such failure to give notice. In case any action, proceeding or claim is brought against an Indemnified Party in
respect of which indemnification is sought hereunder, the indemnifying party shall be entitled to participate in and, unless in
the reasonable judgment of the Indemnified Party a conflict of interest between it and the indemnifying party may exist with respect
of such action, proceeding or claim, to assume the defense thereof with counsel reasonably satisfactory to the Indemnified Party.
In the event that the indemnifying party advises an Indemnified Party that it will contest such a claim for indemnification hereunder,
or fails, within thirty (30) days of receipt of any indemnification notice to notify, in writing, such person of its election
to defend, settle or compromise, at its sole cost and expense, any action, proceeding or claim (or discontinues its defense at
any time after it commences such defense), then the Indemnified Party may, at its option, defend, settle or otherwise compromise
or pay such action or claim. In any event, unless and until the indemnifying party elects in writing to assume and does so assume
the defense of any such claim, proceeding or action, the Indemnified Party’s costs and expenses arising out of the defense,
settlement or compromise of any such action, claim or proceeding shall be losses subject to indemnification hereunder. The Indemnified
Party shall cooperate fully with the indemnifying party in connection with any negotiation or defense of any such action or claim
by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Indemnified
Party which relates to such action or claim. The indemnifying party shall keep the Indemnified Party fully apprised at all times
as to the status of the defense or any settlement negotiations with respect thereto. If the indemnifying party elects to defend
any such action or claim, then the Indemnified Party shall be entitled to participate in such defense with counsel of its choice
at its sole cost and expense. The indemnifying party shall not be liable for any settlement of any action, claim or proceeding
effected without its prior written consent, provided, however, that the indemnifying party shall be liable for any
settlement if the indemnifying party is advised of the settlement but fails to respond to the settlement within thirty (30) days
of receipt of such notification. Notwithstanding anything in this Article VI to the contrary, the indemnifying party shall not,
without the Indemnified Party’s prior written consent, settle or compromise any claim or consent to entry of any judgment
in respect thereof which imposes any future obligation on the Indemnified Party or which does not include, as an unconditional
term thereof, the giving by the claimant or the plaintiff to the Indemnified Party of a release from all liability in respect
of such claim. The indemnification required by this Article VI shall be made by periodic payments of the amount thereof during
the course of investigation or defense, as and when bills are received or expense, loss, damage or liability is incurred, so long
as the Indemnified Party irrevocably agrees to refund such moneys if it is ultimately determined by a court of competent jurisdiction
that such party was not entitled to indemnification. The indemnity agreements contained herein shall be in addition to (a) any
cause of action or similar rights of the Indemnified Party against the indemnifying party or others, and (b) any liabilities the
indemnifying party may be subject to pursuant to the law.

 

    13

     

    

 

ARTICLE
VII

 

Miscellaneous

 

Section
7.1 Fees and Expenses. Except as otherwise set forth in this Agreement, each party shall pay the fees and expenses of
its advisors, counsel, accountants and other experts, if any, and all other expenses, incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement.

 

Section
7.2 Specific Enforcement, Consent to Jurisdiction.

 

(a) The
Company and the Purchaser acknowledge and agree that irreparable damage would occur in the event that any of the provisions of
this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed
that the parties shall be entitled to an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement
and to enforce specifically the terms and provisions hereof or thereof, this being in addition to any other remedy to which any
of them may be entitled by law or equity.

 

(b) Each
of the Company and the Purchaser (i) hereby irrevocably submits to the jurisdiction of the United States District Court sitting
in the Southern District of New York and the courts of the State of New York located in New York county for the purposes of any
suit, action or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby or thereby and
(ii) hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of
the suit, action or proceeding is improper. Each of the Company and the Purchaser consents to process being served in any such
suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of
delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing in this Section 7.2 shall affect or limit any right to serve
process in any other manner permitted by law. Each party hereby irrevocably waives personal service of process and consents to
process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices
to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.
Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.

 

Section
7.3 Entire Agreement; Amendment. This Agreement contains the entire understanding and agreement of the parties with
respect to the matters covered hereby and, except as specifically set forth herein, neither the Company nor any of the Purchaser
makes any representations, warranty, covenant or undertaking with respect to such matters and they supersede all prior understandings
and agreements with respect to said subject matter, all of which are merged herein. No provision of this Agreement may be waived
or amended other than by a written instrument signed by the Company and the Purchaser, and no provision hereof may be waived other
than by a written instrument signed by the party against whom enforcement of any such waiver is sought.

 

    14

     

    

 

Section
7.4 Notices. All notices, demands, consents, requests, instructions and other communications to be given or delivered
or permitted under or by reason of the provisions of this Agreement or in connection with the transactions contemplated hereby
shall be in writing and shall be deemed to be delivered and received by the intended recipient as follows: (i) if personally delivered,
on the business day of such delivery (as evidenced by the receipt of the personal delivery service), (ii) if mailed certified
or registered mail return receipt requested, two (2) business days after being mailed, (iii) if delivered by overnight courier
(with all charges having been prepaid), on the business day of such delivery (as evidenced by the receipt of the overnight courier
service of recognized standing), or (iv) if delivered by facsimile transmission, on the business day of such delivery if sent
by 6:00 p.m. in the time zone of the recipient, or if sent after that time, on the next succeeding business day (as evidenced
by the printed confirmation of delivery generated by the sending party’s telecopier machine). If any notice, demand, consent,
request, instruction or other communication cannot be delivered because of a changed address of which no notice was given (in
accordance with this Section 7.4), or the refusal to accept same, the notice, demand, consent, request, instruction or other communication
shall be deemed received on the second business day the notice is sent (as evidenced by a sworn affidavit of the sender). All
such notices, demands, consents, requests, instructions and other communications will be sent to the following addresses or facsimile
numbers as applicable:

 

If
to the Company:

 

Third
floor, Borough A, Block A. No. 181, South Taibai Road

Xi’an,
Shaanxi Province,

People’s
Republic of China 710065

Attn:
Mr. Zhuoyu Li, CEO

Telephone
No.: +86-29-88266368

 

If
to Purchaser:  

 

The
address listed on Exhibit B

 

Any
party hereto may from time to time change its address for notices by giving at least ten (10) days written notice of such changed
address to the other party hereto.

 

Section
7.5 Waivers. No waiver by any party of any default with respect to any provision, condition or requirement of this Agreement
shall be deemed to be a continuing waiver in the future or a waiver of any other provisions, condition or requirement hereof,
nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right
accruing to it thereafter.

 

Section
7.6 Headings. The section headings contained in this Agreement (including, without limitation, section headings and
headings in the exhibits and schedules) are inserted for reference purposes only and shall not affect in any way the meaning,
construction or interpretation of this Agreement. Any reference to the masculine, feminine, or neuter gender shall be a reference
to such other gender as is appropriate. References to the singular shall include the plural and vice versa.

 

Section
7.7 Successors and Assigns. This Agreement may not be assigned by a party hereto without the prior written consent of
the Company or the Purchaser, as applicable, provided, however, that, subject to federal and state securities laws,
a Purchaser may assign its rights and delegate its duties hereunder in whole or in part to an affiliate or to a third party acquiring
all or substantially all of its Shares in a private transaction without the prior written consent of the Company or the other
Purchaser, after notice duly given by such Purchaser to the Company provided, that no such assignment or obligation shall
affect the obligations of such Purchaser hereunder and that such assignee agrees in writing to be bound, with respect to the transferred
securities, by the provisions hereof that apply to the Purchaser. The provisions of this Agreement shall inure to the benefit
of and be binding upon the respective permitted successors and assigns of the parties. Nothing in this Agreement, express or implied,
is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies,
obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

    15

     

    

 

Section
7.8 Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State
of New York, without giving effect to any of the conflicts of law principles which would result in the application of the substantive
law of another jurisdiction. This Agreement shall not be interpreted or construed with any presumption against the party causing
this Agreement to be drafted.

 

Section
7.9 Survival. The representations and warranties of the Company and the Purchaser shall survive the execution and delivery
hereof and the Closing hereunder for a period of three (3) years following the Closing Date.

 

Section
7.10 Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed shall
be deemed to be an original and, all of which taken together shall constitute one and the same Agreement and shall become effective
when counterparts have been signed by each party and delivered to the other parties hereto, it being understood that all parties
need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, such signature shall
create a valid binding obligation of the party executing (or on whose behalf such signature is executed) the same with the same
force and effect as if such facsimile signature were the original thereof.

 

Section
7.11 Severability. The provisions of this Agreement are severable and, in the event that any court of competent jurisdiction
shall determine that any one or more of the provisions or part of the provisions contained in this Agreement shall, for any reason,
be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect
any other provision or part of a provision of this Agreement and such provision shall be reformed and construed as if such invalid
or illegal or unenforceable provision, or part of such provision, had never been contained herein, so that such provisions would
be valid, legal and enforceable to the maximum extent possible.

 

 Section
7.12 Individual Capacity. Each Purchaser enters into this Agreement on its own capacity, and not as a group with other
Purchasers. Each Purchaser, severally but not jointly, makes representations and warranties contained under this Agreement.

 

Section
7.13 Termination. This Agreement may be terminated prior to Closing by mutual written agreement of the Purchaser and the
Company.

 

Section
7.14. Language. The Agreement is in both English and Chinese, which both have binding effects. If there is any conflict
between the English and Chinese language, English language prevails.

 

[Remainder
of Page Intentionally Left Blank; Signature Pages Follow]

 

    16

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officer as of
the date first above written.

 

	The
    Company:	China
    Green Agriculture, Inc.
	 	 	 
	 	By:	     
	 	 	Name:	Zhuoyu
    Li
	 	 	Title:	Chief
    Executive Officer

 

    17

     

    

 

Signature
Page of the Purchaser

 

IN
WITNESS WHEREOF, the Purchaser has caused this Agreement to be duly executed individually or by its authorized officer or member
as of the date first above written.

 

The
Purchaser: 

 

By:
 ___________________

 

Entity
Name: ___________________

 

Number
of Shares Purchased: ___________________

Total
Purchase Price: ($1.00 x Number of Shares Purchased) $                 

 

Address
and Contacts of Purchaser 

 

    18

     

    

 

EXHIBIT
A TO

THE
SECURITIES PURCHASE AGREEMENT

 

 

 

 NON
U.S. PERSON REPRESENTATIONS 

 

The
Purchaser indicating that it is not a U.S. person, severally and not jointly, further represents and warrants to the Company as
follows:

 

		1.	At
                                         the time of (a) the offer by the Company and (b) the acceptance of the offer by such
                                         person or entity, of the Shares, such person or entity was outside the United States.

 

		2.	Such
                                         person or entity is acquiring the Shares for such Shareholder’s own account, for
                                         investment and not for distribution or resale to others and is not purchasing the Shares
                                         for the account or benefit of any U.S. person, or with a view towards distribution to
                                         any U.S. person, in violation of the registration requirements of the Securities Act.

 

		3.	Such
                                         person or entity will make all subsequent offers and sales of the Shares either (x) outside
                                         of the United States in compliance with Regulation S; (y) pursuant to a registration
                                         under the Securities Act; or (z) pursuant to an available exemption from registration
                                         under the Securities Act. Specifically, such person or entity will not resell the Shares
                                         to any U.S. person or within the United States prior to the expiration of a period commencing
                                         on the Closing Date and ending on the date that is one year thereafter (the “Distribution
                                         Compliance Period”), except pursuant to registration under the Securities Act
                                         or an exemption from registration under the Securities Act.

 

		4.	Such
                                         person or entity has no present plan or intention to sell the Shares in the United States
                                         or to a U.S. person at any predetermined time, has made no predetermined arrangements
                                         to sell the Shares and is not acting as a Distributor of such securities.

 

		5.	Neither
                                         such person or entity, its Affiliates nor any Person acting on behalf of such person
                                         or entity, has entered into, has the intention of entering into, or will enter into any
                                         put option, short position or other similar instrument or position in the U.S. with respect
                                         to the Shares at any time after the Closing Date through the Distribution Compliance
                                         Period except in compliance with the Securities Act.

 

		6.	Such
                                         person or entity consents to the placement of a legend on any certificate or other document
                                         evidencing the Shares substantially in the form set forth in Section 5.1.

 

		7.	Such
                                         person or entity is not acquiring the Shares in a transaction (or an element of a series
                                         of transactions) that is part of any plan or scheme to evade the registration provisions
                                         of the Securities Act.

 

		8.	Such
                                         person or entity has sufficient knowledge and experience in finance, securities, investments
                                         and other business matters to be able to protect such person’s or entity’s
                                         interests in connection with the transactions contemplated by this Agreement.

 

    19

     

    

 

		9.	Such
                                         person or entity has consulted, to the extent that it has deemed necessary, with its
                                         tax, legal, accounting and financial advisors concerning its investment in the Shares.

 

		10.	Such
                                         person or entity understands the various risks of an investment in the Shares and can
                                         afford to bear such risks for an indefinite period of time, including, without limitation,
                                         the risk of losing its entire investment in the Shares.

 

		11.	Such
                                         person or entity has had access to the Company’s publicly filed reports with the
                                         SEC and has been furnished during the course of the transactions contemplated by this
                                         Agreement with all other public information regarding the Company that such person or
                                         entity has requested and all such public information is sufficient for such person or
                                         entity to evaluate the risks of investing in the Shares.

 

		12.	Such
                                         person or entity has been afforded the opportunity to ask questions of and receive answers
                                         concerning the Company and the terms and conditions of the issuance of the Shares.

 

		13.	Such
                                         person or entity is not relying on any representations and warranties concerning the
                                         Company made by the Company or any officer, employee or agent of the Company, other than
                                         those contained in this Agreement.

 

		14.	Such
                                         person or entity will not sell or otherwise transfer the Shares unless either (A) the
                                         transfer of such securities is registered under the Securities Act or (B) an exemption
                                         from registration of such securities is available.

 

		15.	Such
                                         person or entity represents that the address furnished on its signature page to this
                                         Agreement is the principal residence if he is an individual or its principal business
                                         address if it is a corporation or other entity.

 

		16.	Such
                                         person or entity understands and acknowledges that the Shares have not been recommended
                                         by any federal or state securities commission or regulatory authority, that the foregoing
                                         authorities have not confirmed the accuracy or determined the adequacy of any information
                                         concerning the Company that has been supplied to such person or entity and that any representation
                                         to the contrary is a criminal offense.

 

The
Purchaser: 

 

By:
 ___________________

 

    20

     

    

 

Exhibit
B

List
of Purchasers

 

	No.	Shares	Name	Address
    
	1	6,000,000	Shaanxi
    Baoyu Science and Technology Investment Company	86
        Gaoxin Rd B-1-6F

        Xi’an,
        Shaanxi Province 710075

        P.R.
        China

	Total	6,000,000	 

 

    21

     

    

 

Schedules

to
Securities Purchase Agreement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}]]